SG Biosciences COVID-Flu-RSV Kit Approved by MFDS Quantum dot technology ensures high accuracy in simultaneous virus detection ...

Jack Shotbolt was driving through his west Omaha neighborhood in early June when a girl, maybe age 10, shot out in front of ...

A high reading of Escherichia coli (E. coli) bacteria was recorded this week for a northeast Nebraska public swimming beach ...

The point-of-care molecular diagnostics Market is experiencing robust growth, driven by the increasing demand for rapid, accurate, and decentralized diagnostic testing across infectious diseases, ...

A medical testing company will pay nearly $5 million to settle claims of overcharging for COVID-19 tests. GS Labs was accused of charging above-market rates and adding hidden fees despite advertising ...

PENNSYLVANIA (WTAJ) — Attorney General Dave Sunday announced that Pennsylvania is part of a $4.87 million multistate settlement with a company that has allegedly been overcharging patients and failing ...

SEATTLE — Washington residents who paid for COVID-19 tests through GS Labs during the pandemic could soon receive a share of nearly $1 million in restitution under a bipartisan multistate settlement ...

Nearly $1 million in restitution is being repaid to Washingtonians following a multistate settlement with a COVID-19 testing lab that overcharged its patients and failed to deliver timely results. An ...

Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against ...

A chronic lack of investment in development of better tests has left clinicians blind and allows deadly viruses to spread unchecked. By Stephanie Nolen Stephanie Nolen reports on global health, ...

Concerns about rising hantavirus cases has Americans reflecting on the coronavirus pandemic. Although COVID-19 began with a foreign strain and spread rapidly around the world, experts say it’s not ...

Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...